AlphaFold 3

Predicting the structures and interactions of all of life's molecules with unprecedented accuracy.

by Isomorphic Labs · Drug Discovery AI

AlphaFold 3 screenshot

Executive Summary

AlphaFold 3 is an artificial intelligence and foundation model platform co-developed with Google DeepMind. It is capable of predicting the structures and interactions of all of life's molecules with unprecedented accuracy, marking a significant advancement in structural biology. This new AI model allows scientists to input a description of a biomolecular complex they are interested in, and it predicts the 3D structure of that complex. It accurately predicts the structure of proteins, DNA, RNA, ligands, and more, as well as how they interact. AlphaFold 3 is a powerful tool for rational drug design, offering a glimpse into the next generation of biological research and therapeutic development by enabling a deeper understanding of molecular biology.

Use Cases

  • Rational drug design and discovery
  • Predicting protein structures and interactions
  • Understanding DNA and RNA structures
  • Analyzing ligand binding and interactions
  • Accelerating therapeutic development

Features

Intelligence

  • 3D Structure Prediction: Accurately predicts the 3D structure of proteins, DNA, RNA, ligands, and other biomolecules.
  • Molecular Interaction Prediction: Predicts how different molecules interact with each other within a complex, including protein-ligand, protein-DNA, and protein-RNA interactions.

Pricing

Target Customer
Enterprise

About Isomorphic Labs

Isomorphic Labs is an AI-first drug design and development company, established as an Alphabet company. It leverages machine learning to reimagine and accelerate the drug discovery process, aiming to model complex biological phenomena to design novel molecules and develop innovative medicines.

Founded: 2021 · Headquarters: London, United Kingdom · Employees: 201-500 · Private

Alternatives to AlphaFold 3

  • AtomNet by Atomwise — Deep-learning virtual screening to find novel small-molecule hits faster
  • BenevolentAI Platform by BenevolentAI — AI-driven drug discovery: accelerating science, transforming medicine.
  • Chemistry42 by Insilico Medicine — A generative AI platform for small molecule drug discovery, streamlining hit identification to lead optimization.
  • ChemML Discovery Platform by Insitro — Accelerating drug discovery through chemistry machine learning and strategic collaborations.
  • Cortellis by Clarivate — Equip your R&D ecosystem with intelligence to make confident, speedy decisions across drug and device development.
  • Cyprotex by Evotec — Predictive ADME-Tox solutions for enhanced drug safety and success.
  • DORA by Insilico Medicine — AI-driven tool to streamline academic paper drafting and accelerate drug discovery research.
  • DRG Fusion by Clarivate — Ignite commercial success in life sciences and healthcare with modular analytics powered by real-world data.

Keep researching